Lupin 2024

Aurobindo receives approval for valganciclovir for oral solution

Aurobindo receives approval for valganciclovir for oral solution

Aurobindo receives approval for valganciclovir for oral solution

EAST WINDSOR, N.J. – Aurobindo Pharma’s valganciclovir for oral solution, are an AB-rated generic equivalent to the reference listed drug (RLD), VALCYTE for oral solution 50mg/1mL, manufactured by HOFFMANN LA ROCHE. Valganciclovir for oral solution, are indicated for the prevention of Cytomegalovirus (CMV) disease in kidney and heart transplant patients at high risk. Valganciclovir for

PP_1170x120_10-25-21